Picture of ExpreS2ion Biotech Holding AB logo

EXPRS2 — ExpreS2ion Biotech Holding AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Expres2ion Q4 Loss After Financial Items Widens To SEK 18.8 Mln

Feb 25 (Reuters) - ExpreS2ion Biotech Holding AB
 EXPRS2.ST :
    * EXPRES2ION ANNOUNCES 2020 FOURTH QUARTER AND FULL-YEAR
RESULTS
    * Q4 NET SALES AMOUNTED TO 5,277 (3,611) KSEK.
    * Q4 RESULT AFTER FINANCIAL ITEMS AMOUNTED TO -18,772
(-7,502)
KSEK.

Source text for Eikon:  ID:nWkr8y3zkf 
Further company coverage:  EXPRS2.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on ExpreS2ion Biotech Holding AB

See all news